These findings collectively demonstrate that the therapeutic effects of FOA triterpenic acid extract on gastric cancer are achieved through the inhibition of gastric cancer cell proliferation, migration, and invasion, induction of apoptosis, G1 phase cell cycle arrest, and elevation of Caspase-3 levels. The gene discussed is CASP3; the disease is gastric cancer.